CMV-MVA Triplex Vaccine to Enhance Adaptive NK Cell Reconstitution After Autologous Hematopoietic Cell Transplantation in Patients With Lymphoid Malignancies
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2019
At a glance
- Drugs MVA CMV (Primary)
- Indications Cytomegalovirus infections
- Focus Pharmacodynamics
- 07 Jan 2019 Status changed from not yet recruiting to recruiting.
- 26 Nov 2018 Planned End Date changed from 1 Jun 2020 to 1 Aug 2020.
- 26 Nov 2018 Planned primary completion date changed from 1 Jun 2020 to 1 Aug 2020.